跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 201 条关于
“Myostatin”
全部
201
临床试验
137
药物
23
机构
0
资讯
41
去年
Scholar Rock's Myostatin-Blocking Antibody Advances to FDA Review for Spinal Muscular Atrophy
去年
iBio Advances AI-Driven Obesity Pipeline with Myostatin and Activin E Antibody Therapies
去年
Biohaven's Taldefgrobep Alfa Shows Promise in Obesity Despite SMA Trial Setback
去年
Scholar Rock's Apitegromab Preserves Lean Muscle Mass During Weight Loss with Tirzepatide in Phase 2 Trial
去年
Scholar Rock's Apitegromab Shows Promise in Spinal Muscular Atrophy Treatment
去年
Scholar Rock Submits Apitegromab BLA to FDA for Spinal Muscular Atrophy Treatment
6个月前
iBio Advances Bispecific Antibody for Pulmonary Hypertension in Heart Failure, Targets Q3 2026 Development Candidate
去年
FDA Sets Q3 2025 Approval Dates for Three Breakthrough Therapies Targeting Rare Diseases
7个月前
NorthStrive Biosciences Advances EL-32 Manufacturing for Muscle Preservation in GLP-1 Therapy Patients
去年
Scholar Rock Appoints David L. Hallal as CEO, Strengthens Leadership Team Ahead of Apitegromab Launch for SMA
第 1 页,共 5 页
上一页
下一页